Accelerated FDA approval will invite recklessness. But don't block these important medications. Take steps to prepare.

Open-source OCR from Baidu eliminates the GPU memory wall that limits long-document parsing. Unlimited OCR uses a constant KV ...

After my husband’s death, I had never been more pliable, tender, open, or raw. It was then that I tried E.M.D.R. therapy.

Pisces enters July 4, 2026 with a highly sensitive, intuitive, and reflective energy that can shape the day in meaningful ...

Summary: Late-onset Alzheimer’s disease represents one of the most pervasive, devastating neurodegenerative crises globally.

By Pietro Antonio Ciclese, Senior Technical Marketing Engineer, Ambarella The workloads that generate the most commercial ...

Explore the evolution of pain understanding, from ancient philosophies to modern interdisciplinary treatments in pain ...

AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...

Introduction By 2050, two-thirds of people with dementia will live in low-and-middle-income countries (LMICs). However, multimodal prevention lifestyle interventions for people at risk are being ...

AbbVie today announced that the European Commission (EC) has approved SKYRIZI® (risankizumab) for the treatment of children and adolescents six years of age and older with moderate to severe plaque ...

What the Machine Draws From To give a few examples: when Milton Glaser drew, he drew on Mantegna, on American comics, on ...